Alimentary pharmacology & therapeutics

The most recent articles from: Aliment. Pharmacol. Ther. August 2009

Aliment. Pharmacol. Ther. · Aug 2009

Randomized Controlled Trial

Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study.

Intestinal immune infiltration contributes to symptoms in patients with irritable bowel syndrome (IBS). ⋯ Mesalazine is an effective and safe approach to reduce mast cell infiltration and may improve general well-being in patients with IBS. These results support the hypothesis that immune mechanisms represent potential therapeutic targets in IBS.

expand abstract… mark as read…
Aliment. Pharmacol. Ther. · Aug 2009

Comment Letter Comparative Study

Fentanyl vs. pethidine as sedation for gastrointestinal endoscopy.

no abstract available

read on… or not…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.